Asia Pacific Diagnostic Catheter Market Size is valued at USD 560 Million in 2019 and estimated to be growing at a CAGR of 7.8%, to reach USD 810million by 2024 during the forecast period 2019-2024.
Catheters are thin tubes made of medical grade material such as plastic, silicon rubber, polyvinyl chloride (PVC), and nylon.
Catheterization is a primary co-procedure performed with varied other medical procedures such as angioplasty, cardiac electrophysiology, and neurosurgery, wherein catheters are used. Various drivers of the market include the presence of a large patient population, increased patient awareness for minimally invasive surgeries, a rapid rise in prevalence of cardiovascular and kidney disorders, growth in per capita income, and increasing investments in the healthcare industry by key market players. However, inadequate quality assurance and price competition at domestic levels are expected to hamper this growth.
This research report on Asia Pacific Diagnostic Catheter Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast for each segment until 2024.
By Type: Imaging catheters, Non-imaging catheters.
By Application: Neurology, Urology, Gastroenterology, Cardiology , Others (Bronchoscopy and Gynecology).
By End-user: Hospitals , Imaging & Diagnostic Centers.
By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC.
Asia-Pacific is expected to witness the highest growth during the forecast period.
Noteworthy Companies leading the Asia Pacific Diagnostic Catheter Market Profiled in the Report are Boston Scientific Corporation (U.S.), St. Jude Medical, Inc. (U.S.), Medtronic plc (Ireland), Johnson & Johnson (U.S.), Koninklijke Philips N.V. (Netherlands), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Cardinal Health, Inc. (U.S.), Edward Lifesciences Corporation (U.S.), and Terumo Corporation (Japan).
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Type
5.1.1 Introduction
5.1.2 Imaging catheters
5.1.2.1 Electrophysiology catheters
5.1.2.1.1 Advanced EP catheters
5.1.2.1.2 Conventional EP catheters
5.1.2.2 OCT catheters
5.1.2.3 Ultrasound catheters
5.1.2.4 Angiography catheters
5.1.2.5 Other imaging catheters
5.1.3 Non imaging catheters
5.1.3.1 Pressure & Hemodynamic monitoring Catheters
5.1.3.2 Temperature monitoring Catheters
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
5.2 Application
5.2.1 Introduction
5.2.2 Neurology
5.2.3 Urology
5.2.4 Gastroenterology
5.2.5 Cardiology
5.2.6 Others ( Bronchoscopy and Gynaecology)
5.2.7 Y-o-Y Growth Analysis, By Application
5.2.8 Market Attractiveness Analysis, By Application
5.2.9 Market Share Analysis, By Application
5.3 End user
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Imaging & Diagnostic Centers
5.3.4 Y-o-Y Growth Analysis, By End user
5.3.5 Market Attractiveness Analysis, By End user
5.3.6 Market Share Analysis, By End user
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Application
6.1.3.4 By End user
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Application
6.1.4.4 By End user
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Application
6.1.5.4 By End user
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Boston Scientific Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 St. Jude Medical, Inc.
8.3 Medtronic plc
8.4 Johnson & Johnson
8.5 Koninklijke Philips N.V.
8.6 B. Braun Melsungen AG
8.7 C.R. Bard, Inc.
8.8 Cardinal Health, Inc.
8.9 Edward LifeSciences Corporation
8.10 Terumo Corporation
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
